Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research Article
  • Published:

A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients

Abstract

For several decades, lithium has been the drug of choice in the long-term treatment of manic-depressive illness, but the molecular mechanism(s) mediating its therapeutic effects remain to be determined. The enzyme myo-inositol monophosphatase (IMPase) in the phospholipase C signaling system is inhibited by lithium at therapeutically relevant concentrations, and is a candidate target of lithium's mood-stabilizing action. Two genes encoding human IMPases have so far been isolated, namely IMPA1 on chromosome 8q21.13–21.3 and IMPA2 on chromosome 18p11.2. Interestingly, several studies have indicated the presence of a susceptibility locus for bipolar disorder on chromosome 18p11.2. IMPA2 is therefore a candidate for genetic studies on both etiology and lithium treatment of manic-depressive illness. Here we report that the genomic structure of IMPA2 is composed of eight exons, ranging in size from 46 bp to 535 bp. the promoter region contains several sp1 elements and lacks a tata-box, features typical for housekeeping genes. by a preliminary polymorphism screening of exons 2–8 in a sample of 23 norwegian bipolar patients, we have identified nine single nucleotide polymorphisms (snps). seven of the polymorphisms were located in the introns, one was a silent transition in exon 2 (159t>c) and one was a transition in exon 5 (443g>A) resulting in a predicted amino acid substitution (R148Q). Our data show that even in a small sample of bipolar patients, several variants of the IMPA2 gene can be identified. IMPA2 is therefore an intriguing candidate gene for future association studies of manic-depressive illness.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Goodwin FK, Jamison KR . Manic-depressive Illness Oxford University Press: New York 1990

    Google Scholar 

  2. Peselow ED, Fieve RR, Difiglia C, Sanfilipo MP . Lithium prophylaxis of bipolar illness. The value of combination treatment BrJ Psychiatry 1994; 164: 208–214

    Article  CAS  Google Scholar 

  3. Maj M, Pirozzi R, Magliano L . Late non-response to lithium prophylaxis in bipolar patients: prevalence and predictors J Affect Disord 1996; 39: 39–42

    Article  CAS  Google Scholar 

  4. Vestergaard P, Wentzer LR, Brodersen A, Rasmussen NA, Christensen H, Arngrim T et al. Outcome of lithium prophylaxis: a prospective follow-up of affective disorder patients assigned to high and low serum lithium levels Acta Psychiatr Scand 1998; 98: 310–315

    Article  CAS  Google Scholar 

  5. Manji HK, Potter WZ, Lenox RH . Signal transduction pathways. Molecular targets for lithium's actions Arch Gen Psychiatry 1995; 52: 531–543

    Article  CAS  Google Scholar 

  6. Lenox RH, McNamara RK, Papke RL, Manji HK . Neurobiology of lithium: an update J Clin Psychiatry 1998; 59: 37–47

    CAS  PubMed  Google Scholar 

  7. Berridge MJ, Downes CP, Hanley MR . Neural and developmental actions of lithium: a unifying hypothesis Cell 1989; 59: 411–419

    Article  CAS  Google Scholar 

  8. Allison JH, Blisner ME, Holland WH, Hipps PP, Sherman WR . Increased brain myo-inositol 1-phosphate in lithium-treated rats Biochem Biophys Res Commun 1976; 71: 664–670

    Article  CAS  Google Scholar 

  9. Berridge MJ, Downes CP, Hanley MR . Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands Biochem J 1982; 206: 587–595

    Article  CAS  Google Scholar 

  10. Dixon JF, Lee CH, Los GV, Hokin LE . Lithium enhances accumulation of [3H]inositol radioactivity and mass of second messenger inositol 1,4,5-trisphosphate in monkey cerebral cortex slices J Neurochem 1992; 59: 2332–2335

    Article  CAS  Google Scholar 

  11. Kennedy ED, Challiss RA, Ragan CI, Nahorski SR . Reduced inositol polyphosphate accumulation and inositol supply induced by lithium in stimulated cerebral cortex slices Biochem J 1990; 267: 781–786

    Article  CAS  Google Scholar 

  12. del Rio E, Shinomura T, van der Kaay J, Nicholls DG, Downes CP . Disruption by lithium of phosphoinositide signalling in cerebellar granule cells in primary culture J Neurochem 1998; 70: 1662–1669

    Article  CAS  Google Scholar 

  13. Steen VM, Løvlie R, Osher Y, Belmaker RH, Berle J, Gulbrandsen AK . The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness Pharmacogenetics 1998; 8: 259–268

    CAS  PubMed  Google Scholar 

  14. Steen VM, Gulbrandsen AK, Eiken HG, Berle J . Lack of genetic variation in the coding region of the myo-inositol monophosphatase gene in lithium-treated patients with manic depressive illness Pharmacogenetics 1996; 6: 113–116

    Article  CAS  Google Scholar 

  15. Sjøholt G, Molven A, Løvlie R, Wilcox A, Sikela JM, Steen VM . Genomic structure and chromosomal localization of a human myo-inositol monophosphatase gene (IMPA) Genomics 1997; 45: 113–122

    Article  Google Scholar 

  16. Yoshikawa T, Turner G, Esterling LE, Sanders AR, Detera-Wadleigh SD . A novel human myo-inositol monophosphatase gene, IMP.18p, maps to a susceptibility region for bipolar disorder Mol Psychiatry 1997; 2: 393–397

    Article  CAS  Google Scholar 

  17. York JD, Ponder JW, Majerus PW . Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure Proc Natl Acad Sci USA 1995; 92: 5149–5153

    Article  CAS  Google Scholar 

  18. Berrettini WH, Ferraro TN, Goldin LR, Weeks DE, Detera-Wadleigh S, Nurnberger JI et al. Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene Proc Natl Acad Sci USA 1994; 91: 5918–5921

    Article  CAS  Google Scholar 

  19. Stine OC, Xu J, Koskela R, McMahon FJ, Gschwend M, Friddle C et al. Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect Am J Hum Genet 1995; 57: 1384–1394

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Nöthen MM, Cichon S, Rohleder H, Hemmer S, Franzek E, Fritze J et al. Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families Mol Psychiatry 1999; 4: 76–84

    Article  Google Scholar 

  21. Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G et al. A high-density genome scan detectsevidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2 Proc Natl Acad Sci USA 1999; 96: 5604–5609

    Article  CAS  Google Scholar 

  22. Schwab SG, Hallmayer J, Lerer B, Albus M, Borrmann M, Honig S et al. Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis Am J Hum Genet 1998; 63: 1139–1152

    Article  CAS  Google Scholar 

  23. Shamir A, Ebstein RP, Nemanov L, Zohar A, Belmaker RH, Agam G . Inositol monophosphatase in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy Mol Psychiatry 1998; 3: 481–482

    Article  CAS  Google Scholar 

  24. Ausubel FM, Brent R, Kingston RE, Moore D, Seidman JG, Smith JA et al. Current Protocols in Molecular Biology John Wiley and Sons: New York 1996

    Google Scholar 

  25. Azizkhan JC, Jensen DE, Pierce AJ, Wade M . Transcription from TATA-less promoters: dihydrofolate reductase as a model Crit Rev Eukaryot Gene Expr 1993; 3: 229–254

    CAS  PubMed  Google Scholar 

  26. Schuller HJ, Richter K, Hoffmann B, Ebbert R, Schweizer E . DNA binding site of the yeast heteromeric Ino2p/Ino4p basic helix-loop-helix transcription factor: structural requirements as defined by saturation mutagenesis FEBS Lett 1995; 370: 149–152

    Article  CAS  Google Scholar 

  27. Van Dijken P, Bergsma JC, Hiemstra HS, De Vries B, Van Der Kaay J, Van Haastert PJ . Dictyostelium discoideum contains three inositol monophosphatase activities with different substrate specificities and sensitivities to lithium Biochem J 1996; 314: 491–495

    Article  CAS  Google Scholar 

  28. Gillaspy GE, Keddie JS, Oda K, Gruissem W . Plant inositol monophosphatase is a lithium-sensitive enzyme encoded by a multigene family Plant Cell 1995; 7: 2175–2185

    Article  CAS  Google Scholar 

  29. Antonarakis SE . Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group Hum Mutat 1998; 11: 1–3

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study has been supported by Dr Einar Martens’ Research Fund, the Research Council of Norway (Mental Health Program) and in part by Eva Torhild's Memorial Fund for Medical Research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V M Steen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sjøholt, G., Gulbrandsen, A., Løvlie, R. et al. A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients. Mol Psychiatry 5, 172–180 (2000). https://doi.org/10.1038/sj.mp.4000681

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.mp.4000681

Keywords

This article is cited by

Search

Quick links